T~h~1/T~h~2 paradigm theorizing for allergic diseases is on the rise
====================================================================

There is an inverse correlation between the levels of endotoxin in house dust and the incidence of atopic sensitization and hay fever \[[@B1]\]. The major role of endotoxin is considered to be the stimulation of macrophages/antigen-presenting cells to produce interleukin 12 (IL-12), which triggers the development of antigen-specific type 1 helper T (T~h~1) cells and inhibits the development of type 2 helper T (T~h~2) cells. As such, the hygiene hypothesis associated with an increasing prevalence of allergic diseases has been theorized by the T~h~1/T~h~2 paradigm \[[@B2]\] since a long time.

Most epidemiological studies supporting the hygiene hypothesis also indicate that the preventive effect on allergy of an \"unhygienic\" environment surrounded by many microbial components is limited to early childhood \[[@B1]\]. According to the classic T~h~1/T~h~2 paradigm theory, this could be typically speculated as shown in Figure [1](#F1){ref-type="fig"}. A T~h~2-dominant immune system develops in an individual when the immune system is exposed to allergens without prior exposure to microbial components such as endotoxin early in life. On the other hand, the development of allergen (antigen)-specific T~h~1 cells is triggered by simultaneous exposure to the antigen and microbial components. After childhood, the proportion of T~h~1/T~h~2 cells is not drastically altered by microbial exposure because of a decrease in the number of naive helper T cells that can react with common allergens.

![**Environment surrounded by microbial components is effective only during early childhood**. Only T~n~\'s are present during infancy. The T~h~2-dominant immune system will develop when the immune system is exposed to allergens without microbial components such as endotoxin. Allergen-associated T~h~2 adjuvants such as prostaglandins may enhance T~h~2 development. On the other hand, antigen/allergen-specific T~h~1 cells can develop by simultaneous exposure to antigen/allergen and microbial components. After childhood, microbial exposure cannot drastically alter the proportion of T~h~1/T~h~2 balance because the proportion of T~n~is decreased. T~n~indicates naive helper T cells.](1939-4551-1-1-9-1){#F1}

The incidence of T~h~1-mediated autoimmune diseases is known to have increased in the last half century in parallel with the increase of T~h~2-mediated allergic diseases \[[@B3]\]. The classic T~h~1/T~h~2 paradigm cannot be used to explain this point.

Roles of various regulatory T-cell populations
==============================================

Several subsets of CD4^+^cells are able to prevent immune responses against self-antigens or allergens. These cells are called regulatory T (T~reg~) cells. Because T~reg~cells inhibit both T~h~1- and T~h~2-cell development in vitro, increases in the incidence of T~h~1 diseases and T~h~2-mediated diseases are now thought to be related to an insufficient development of T~reg~cells. However, there is no evidence yet whether the \"hygienic\" environment with exposure to less microbial components during early life affects the development of T~reg~cells.

Among the several subsets, naturally occurring T~reg~(nT~reg~) cells have been well investigated. These cells originate in the thymus, express the repertoire of CD4^+^CD25^+^(mouse) or CD4^+^CD25^high^(human) and the transcription factor forkhead box protein P3 (Foxp3), and have a major role in modulating the activity of self-reactive cells by inducing the destruction of autoreactive T cells mainly via cell-to-cell contact-dependent mechanisms \[[@B4]\]. Therefore, nT~reg~cells are considered to mainly have a preventive role in autoimmune diseases.

In humans, a population of CD4^+^CD25^high^T cells with regulatory function very similar to nT~reg~cells but derived from peripheral memory CD4^+^CD25^-^T cells has recently been described \[[@B5]\]. They are called adaptive T~reg~(aT~reg~) cells \[[@B6]\] or inducible T~reg~(iT~reg~) cells. One of iT~reg~-cell types is the IL-10-producing type 1 T~reg~(Tr1) cells, whose suppressive function has been well documented in allergy and autoimmunity \[[@B7]\]. The term \"iT~reg~\" is often used for the IL-10-producing Tr1, whereas the term aT~reg~is often used as CD4^+^CD25^high^T cells derived from peripheral memory CD4^+^CD25^-^T cells. Therefore, in this review, we have used the term aT~reg~as Foxp3^+^CD4^+^CD25^high^T cells as shown in the recent review article written by Bacchetta et al \[[@B8]\]. Nevertheless, all subsets of T~reg~cells require a cytokine, transforming growth factor-β (TGF-β), for their development. The IL-10 is also produced not only by Tr1 cells, but also by various cell types including regulatory dendritic cells that can induce aT~reg.~\[[@B9]\] As such, these 2 cytokines play an important role in immune regulation.

Forkhead box protein P3 mutant mice develop an intense multiorgan inflammatory response, including allergic airway inflammation, striking hyperimmunoglobulinemia E, eosinophilia, and dysregulated T~h~1 and T~h~2 cytokine production \[[@B10],[@B11]\]. In humans, genetic defects in Foxp3 cause immune dysregulation, polyendocrinopathy, and enteropathy, X-linked (IPEX) syndrome \[[@B12]\]. Most IPEX patients have food allergy and atopic dermatitis-related symptoms immediately after birth. It is thus suggested that Foxp3^+^T~reg~cells play an important role in regulating common allergic disorders and IPEX. The number of Foxp3^+^T~reg~cells is decreased in skin lesions in patients with atopic dermatitis and in patients with psoriasis \[[@B13]\].

Although Foxp3 is transiently expressed by antigen-activated helper T cells, \[[@B14]\] only persistent and high-level Foxp3 expression is related to the immunosuppressive functions.

IL-17-producing helper T cells that triggered the major revision for T~h~1/T~h~2 theory
=======================================================================================

A major role for the cytokine IL-17 has recently been described in various murine models of immune-mediated tissue injury, organ-specific autoimmunity, allergic disorders, and microbial infections. Interestingly, interferon-γ (IFN-γ) derived from T~h~1 cells often prevents the IL-17-mediated inflammation in mice with experimental autoimmune diseases \[[@B15],[@B16]\]. A T-cell subpopulation that exclusively produces IL-17 (T~h~17) is now credited for causing and sustaining tissue damage. Human and mouse T~h~17 cells may require different sets of cytokines for their development. Thus, the identification of the T~h~17 cells triggered a shift in the immunologists\' perspectives regarding the basis of tissue damage or auto-immune diseases, where for more than 20 years the role of T~h~1 cells was considered paramount \[[@B16]\].

However, it has been recently revealed that the expression of IL-17 in human CD4^+^T cells may be completely different from that in mice \[[@B17]\]. Unlike mouse, human IL-6 and IL-21 do not induce IL-17 expression in either naive or effector T cells. The TGF-β inhibits human T~h~17-cell development but promotes mouse T~h~17-cell development when costimulated with IL-6 \[[@B17]\]. It should also be noted that in human adult peripheral blood, a large proportion of helper T cells can produce both IFN-γ and IL-4. The proportion of T~h~17 cells in peripheral blood CD4^+^cells are consistently less than 1% in the peripheral blood of healthy individuals, and slightly higher among CD4^+^T cells derived from patients with Crohn\'s disease \[[@B18]\]. Autologous T~reg~-cell clones suppress T~h~1 or T~h~2 cells, but not T~h~17 cells \[[@B18]\]. Nevertheless, IL-6 inhibits the development of both human and mouse T~reg~cells \[[@B19]\].

The key cytokine of T~h~17 cells, IL-17, is known to induce the production of proinflammatory cytokines such as tumor necrosis factor-α (TNF-α), IL-1β, IL-6, and proinflammatory chemokines CXCL1, 2, and 8 by acting on various cell types \[[@B20]\]. In humans, sputum IL-17A messenger RNA levels are significantly elevated in patients with asthma as compared with healthy controls \[[@B21]\]. Endogenous IL-17 contributes to the development of allergen-induced airway hyperresponsiveness, and there is also evidence that IL-17 stimulates the release of several cytokines with known capacity for airway remodeling from cells normally residing in the airways \[[@B22]\].

With the discovery of T~h~17 and T~reg~populations, the balancing square model is now needed to explain the pathogenesis of various immunological diseases. It also enables us to explain the epidemiological data demonstrating an increase in allergic diseases (Figure [2](#F2){ref-type="fig"}). According to this model, we speculate that substantial amounts of plant antigens, parasites, molds, viruses, and bacteria are required for balancing the total immune system (Figure [2](#F2){ref-type="fig"}). Autoimmune diseases are now considered to be initiated by an up-regulation of T~h~17 cells and a defect in nT~reg~cell function, whereas peritumor tissues are strikingly infiltrated with Foxp3^+^nT~reg~cells implying that these cells impinge upon immunemediated rejection of the tumor \[[@B23]\].

![**The balancing square model**. The 4 T-cell types (T~h~1, T~h~2, T~h~17, and T~reg~) antagonize each other. The T~h~1-promoting cytokine, IL-12, is inhibitory to T~h~2-cell development, whereas the T~h~2-promoting cytokine, IL-4, blocks T~h~1-cell development. The T~h~1-derived IFN-γ blocks T~h~17-cell development. The T~reg~inhibits the development of both Th1 and Th2 cells by direct contact.](1939-4551-1-1-9-2){#F2}

Role of aT~reg~cells in the onset of allergic diseases
======================================================

Allergic diseases are caused by uncontrolled T~h~2-based immune responses to environmental antigens. It has been demonstrated that healthy nonatopic subjects have detectable IL-10-producing allergen-specific Tr1-like T~reg~cells, whereas the proportion of these T~reg~cells are very low in symptomatic allergic patients \[[@B24]\].

Several studies suggest a possible defect and impaired function of nT~reg~cells in the pathogenesis of immune responses toward allergens. However, like studies on auto-immune diseases, it is often difficult to distinguish the overlapping phenotypic characteristics between T~reg~cells and activated helper T cells \[[@B8]\].

We recently demonstrated that symptomatic atopic patients had a lower Foxp3^+^CD4^+^ratio than asymptomatic controls having similar levels of serum IFN-γ, total immunoglobulin E (IgE), and eosinophils. These results suggest that circulating Foxp3^+^CD4^+^cells regulate unknown factor(s) affecting the onset of allergic diseases, which are unrelated to these T~h~1/T~h~2 markers. Measurement of Foxp3^+^CD4^+^cells has the potential to aid in evaluating the presence of active inflammation, which cannot be evaluated by known T~h~1- and T~h~2-related markers in patients with allergic diseases \[[@B25]\].

One of the many reasonable explanations for this observation is considered as follows, that is, down-regulation of Foxp3^+^aT~reg~cells is often related to up-regulation of T~h~17 cells. In mice, IL-17 activates mast cells to release a proinflammatory cytokine, TNF-α, and thus can cause neutrophilic inflammation \[[@B26]\]. In humans, T~h~17 cells may enhance allergic inflammation by stimulating the tissue resident cells to release TNF-α, and are proven to evoke marked inflammation and airway remodeling. Using the balancing square model, the immunological features of symptomatic allergic diseases may be illustrated as in Figure [3A](#F3){ref-type="fig"}. Among T~h~2-cell subtypes, TNF-α-rich inflammatory T~h~2 (iT~h~2) cells may be developed by stimulation of dendritic cells with T~h~2 adjuvants associated with allergens or thymic stromal lymphopoietin (TSLP) often found in inflammatory tissues in allergic diseases \[[@B27]\]. Thus, iT~h~2 and T~h~17 cells can be both up-regulated in symptomatic allergic patients, where mast cells are also activated. On the other hand, in asymptomatic controls having similar high levels of IgE and eosinophils, both T~h~2 and aT~reg~cells may be up-regulated. Because of T~h~17 cells, the levels of IFN-γ may be kept at considerably high levels. However, these patients are often infected with viruses at the site of inflammatory tissues because of down-regulation of classic T~h~1 cells \[[@B28]\] capable of producing antiviral cytokine IFN-α.

![**Onset of allergic diseases may be determined by the ratio of proinflammatory T-cell subsets (T~h~17 and iT~h~2) versus T~reg~subsets**. A, In patients with chronic allergic diseases, proinflammatory T-cell subsets, that is, T~h~17 cells and T~h~2 cells that are capable of producing high levels of TNF-α (iT~h~2 cells) are upregulated. B, In asymptomatic atopic individuals, T~h~2 cells that are capable of producing IL-10 (rT~h~2 cells) may be up-regulated, and T~h~17 cells may be inactivated.](1939-4551-1-1-9-3){#F3}

Among T~h~2 subsets, IL-10-producing T~reg~cells may be up-regulated in asymptomatic atopic individuals. Mast cells are therefore not activated, despite the presence of high levels of IgE antibodies and constant exposure to common allergens as shown in Figure [3B](#F3){ref-type="fig"}. Nevertheless, it will be necessary to determine why some people do not have marked mast cell activation even though they are sensitized to multiple allergens.

The nT~reg~cells can suppress not only T cells, but also natural killer cells, dendritic cell maturation, and antibody production by B cells \[[@B29]\]. Recently, mast cells and nT~reg~-derived IL-9 are found indispensable in nT~reg~-mediated peripheral tolerance to allograft transplantation in a mouse model \[[@B30]\]. Pollen immunotherapy that is known to induce allergen-specific aT~reg~or Tr1 cells inhibits seasonal increases in IL-9 protein expression and c-Kit^+^mast cell infiltration in the nasal mucosa during the pollen season \[[@B31]\]. It is of particular interest to investigate a further relationship between aT~reg~and mast cells in future studies.

Conclusion
==========

An atopic predisposition is acquired via up-regulation of T~h~2 cells compared with IFN-γ-producing helper T cells (T~h~1 cells and T~h~17 cells) specific for each allergen as shown in Figure [1](#F1){ref-type="fig"}. Numerous epidemiological studies indicate that microbial components affect the balance between these T-cell types \[[@B1]\]. It should be noted, however, that most of the people who acquired an atopic predisposition in a hygienic environment are still asymptomatic or having very mild symptoms \[[@B25]\]. At present, we have no answer as to why some further develop the clinical manifestations of allergic disease, whereas others remain asymptomatic.

We have reported that active atopic patients had a lower Foxp3^+^CD4^+^ratio than asymptomatic controls having similar levels of serum IFN-γ, total IgE, and eosinophils, \[[@B25]\] suggesting that the development of clinical manifestations of allergic diseases may be determined by the ratio of proinflammatory T-cell subsets (T~h~17 and iT~h~2) versus T~reg~subsets. Increased ratio of proinflammatory cytokines (IL-17, TSLP, and IL-6) versus regulatory cytokines (IL-10 and TGF-β) in severe allergic diseases \[[@B8],[@B19],[@B20],[@B27]\] would activate further the balance shift and form a positive feedback loop in chronic inflammation (Figure [4](#F4){ref-type="fig"}). Nevertheless, we will have to identify the factors influencing the balance shift of proinflammatory and regulatory T cell population.

![**A model for development of allergic and autoimmune diseases in the absence of microbial components**. Increased ratio of proinflammatory cytokines (IL-17, TSLP, and IL-6) versus regulatory cytokines (IL-10 and TGF-β) may play a key role in determining inflammatory allergic/autoimmune diseases versus asymptomatic individuals.](1939-4551-1-1-9-4){#F4}

Notes
=====

Supported by the National Institute of Biomedical Innovation Grant ID 05-24.

The authors state that they have no financial relationship with any commercial entity that has an interest in the subject of this article.

Acknowledgements
================

The authors thank Dr. Kimishige Ishizaka for valuable discussion via e-mail.
